We are live on ! Find out more
AVDL

Avadel Pharmaceuticals
AVDL

Delisted

AVDL was delisted on the 11th of February, 2026.

Back to rankings

80 hedge funds and large institutions have $189M invested in Avadel Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 27 increasing their positions, 23 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 23

5% less call options, than puts

Call options by funds: $1.04M | Put options by funds: $1.09M

1.19% less ownership

Funds ownership: 65.88% → 64.7% (-1.2%)

4% less funds holding

Funds holding: 83 → 80 (-3)

13% less capital invested

Capital invested by funds: $217M → $189M (-$27.5M)

23% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 13

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
80
Holders Change
-3
Holders Change %
-3.61%
% of All Funds
1.83%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
10
Increased
27
Reduced
23
Closed
13
Calls
$1.04M
Puts
$1.09M
Net Calls
-$57K
Net Calls Change
+$368K

Top Buyers

Rank Fund Capital Flow
1
BIP
Brandes Investment Partners
California
+$13.2M
2
GTC
Ghost Tree Capital
New York
+$7.48M
3
PCM
Portolan Capital Management
Massachusetts
+$1.85M
4
TCM
Tekla Capital Management
Massachusetts
+$1.67M
5
AC
Armistice Capital
New York
+$1.3M

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$9.64M
2
NC
Nexthera Capital
New York
-$4.15M
3
Morgan Stanley
Morgan Stanley
New York
-$3.78M
4
Renaissance Technologies
Renaissance Technologies
New York
-$3.19M
5
OAM
Oxford Asset Management
United Kingdom
-$2.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
COPPSERS
26
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$568K – – –
EVM
27
Eaton Vance Management
Massachusetts
$506K +$305K +34,700 +100%
CS
28
Candriam SCA
Luxembourg
$452K – – –
Ohio Public Employees Retirement System (OPERS)
29
Ohio Public Employees Retirement System (OPERS)
Ohio
$421K – – –
ECM
30
Endurant Capital Management
California
$406K +$490K +55,700 New
AA
31
ALPS Advisors
Colorado
$392K +$82.2K +9,342 +21%
Susquehanna International Group
32
Susquehanna International Group
Pennsylvania
$377K +$150K +17,093 +49%
TI
33
Trexquant Investment
Connecticut
$331K +$273K +31,030 +216%
State of New Jersey Common Pension Fund D
34
State of New Jersey Common Pension Fund D
New Jersey
$307K – – –
OSAM
35
O'Shaughnessy Asset Management
Connecticut
$270K +$92.3K +10,490 +40%
Group One Trading
36
Group One Trading
Illinois
$238K +$212K +24,106 +280%
FDCDDQ
37
Federation des caisses Desjardins du Quebec
Quebec, Canada
$211K – – –
Goldman Sachs
38
Goldman Sachs
New York
$193K +$1.86K +212 +0.8%
State of Tennessee, Department of Treasury
39
State of Tennessee, Department of Treasury
Tennessee
$170K – – –
SGAM
40
Smith Group Asset Management
Texas
$153K -$6.45K -733 -3%
CLOS
41
Compagnie Lombard Odier SCmA
Switzerland
$139K -$167K -19,000 -50%
ProShare Advisors
42
ProShare Advisors
Maryland
$139K -$27.1K -3,085 -14%
IAMOG
43
Investors Asset Management of Georgia
Georgia
$110K +$41.3K +4,700 +45%
Parallax Volatility Advisers
44
Parallax Volatility Advisers
California
$108K +$130K +14,751 New
CAM
45
Close Asset Management
United Kingdom
$107K – – –
Northern Trust
46
Northern Trust
Illinois
$101K -$2.65K -301 -2%
MYIA
47
Mount Yale Investment Advisors
Colorado
$101K +$121K +13,792 New
Geode Capital Management
48
Geode Capital Management
Massachusetts
$92K – – –
QSS
49
Quantitative Systematic Strategies
Florida
$92K +$111K +12,620 New
US Bancorp
50
US Bancorp
Minnesota
$91K – – –
1
2
3 4

AVDL Hedge Fund Activity: Q1 2018 in Review

80 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q1 2018, worth a combined $189M — down 13% from $217M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of AVDL and 10 opened new positions — a net loss of 3 holders — while 23 trimmed existing stakes and 27 added.

The largest buyer was Brandes Investment Partners, adding an estimated $13.2M. The largest seller was Perceptive Advisors, cutting an estimated $9.64M.

  • 80 institutional investors held Avadel Pharmaceuticals (AVDL) as of Q1 2018, down from 83 in Q4 2017.
  • Funds reported $189M of Avadel Pharmaceuticals stock for Q1 2018, down 13% quarter-over-quarter.
  • 10 funds opened new Avadel Pharmaceuticals positions in Q1 2018 and 13 closed out, a net change of -3 holders.
  • The largest Avadel Pharmaceuticals buyer in Q1 2018 was Brandes Investment Partners, an estimated $13.2M added.
  • The largest Avadel Pharmaceuticals seller in Q1 2018 was Perceptive Advisors, an estimated $9.64M sold.

Based on aggregated 13F filings for Q1 2018.